MRD / Regn No. : 20260000128 Date : 04/06/2026
Patient Name : Saraswathi Varadhan Age & Gender : 43 Yrs. / Female
Contact No. : 9884202342 UHID :
Ht / Wt / BMI : 149.0 / 60 / 27.03 BP S / BP D : 104 / 76
Allergies : NKA Referred By :
   
Problem List : TYPE 2 DM (02/Mar/2026) | DYSLIPIDEMIA (02/Mar/2026) | OBESITY (02/Mar/2026) |
Subjective : BLEEDING IN GUMS,NEW ONSET DM,BLEEDING GUMS
Objective : NONE
Analysis : TYPE 2 DM,DYSLIPDIEMIA
Plan : INCREASE SEMALIX TO 1 MG,SEE ME IN 2 MONTHS  
Salient Investigations : FASTING PLASMA GLUCOSE (FPG): 87 mg/dL | POST PRANDIAL GLUCOSE (2HPP): 110 mg/dL
S# Generic (Trade) Name Route Dosage Usage Duration
1 TABLET DAPAGLIFLOZIN 10 MG
UDAPA
Medicine For DIABETES OBESITY HEART AND KIDNEY PROTECTION
PO 1-0-0 BEFORE FOOD
TILL NEXT VISIT
MAY CAUSE GENITOURINARY INFECTION. INFORM IF THERE IS DYSURIA OR GENITAL ITCHING
2 TABLET FEXOFENADINE 120 MG
ALLEGRA 120 MG
PO 1-0-0 BEFORE FOOD
1 MONTH
3 METRONIDAZOLE 2%W/V GEL
METROGYL GEL
- AS DIRECTED
7 DAYS
4 INJECTION SEMAGLUTIDE 1 MG
SEMALIX 1 MG
Medicine For DIABETES OBESITY
SQ ONCE A WEEK AS DIRECTED NO RELATION TO MEALS
TILL NEXT VISIT
MAY CAUSE VOMITING NAUSEA OR DIARRHEA
       
Refill : 0 / Substitution:    
Education :
Next Visit : 03/Aug/2026
Tests Suggested For Next Visit : FBS 2HPP HBA1C
   
   

Dr. Krishna G Seshadri
Sr. Consultant Endocrinology Diabetes and Metabolism
Tamil Nadu / 48748 HPRID: 71-0638-2075-7542

This is a Computer generated Prescription

Powered By: